MYLAN's $ 50 MIL. ACQUISITION OF DOW B. HICKAM IS NEXT STAGE IN GROWTH OF BRANDNAME DRUG BUSINESS; HICKAM BRINGS 70 SALES REPS AND $ 18 MIL. SALES